ExodusPoint Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

ExodusPoint Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,754	Closed	-$789K	–	2295
2021 Q3	$789K	Buy	4,754 +2,989	+169%	+$511K	0.01%	1141
2021 Q2	$305K	Buy	+1,765	New	+$292K	﹤0.01%	1729

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ExodusPoint Capital Management's FBT Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2021, closing a stake of 4,754 shares — an estimated $789K sold.

ExodusPoint Capital Management first reported a position in FBT in Q2 2021 and held it in 2 quarters. The position peaked at $789K in Q3 2021. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

ExodusPoint Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 4,754 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2021, an estimated $789K.
ExodusPoint Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2021 and held it in 2 quarters.
ExodusPoint Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $789K in Q3 2021.
247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.